CEO of Bolt Biotherapeutics
A biopharmaceutical company developing treatments for migraine and other neurological and inflammatory conditions
Bolt Biotherapeutics is developing its novel BoltbodyTM platform, a cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC).